DNA mechanocapsules for programmable piconewton responsive drug delivery

<p>The mechanical dysregulation of cells is associated with a number of disease states, that spans from fibrosis to tumorigenesis. Hence, it is highly desirable to develop strategies to deliver drugs based on the "mechanical phenotype" of a cell. To achieve this goal, we outline and synthesize DNA mechanocapsules (DMC) comprised of DNA tetrahedrons that are force responsive. Modeling shows&nbsp;the trajectory of force-induced DMC rupture and predicts how applied force spatial position and orientation tunes the force-response threshold. DMCs functionalized with adhesion ligands mechanically denature <i>in vitro</i> as a result of cell receptor forces. &nbsp;DMCs are&nbsp;designed to encapsulate macromolecular cargos such as dextran and oligonucleotide drugs with minimal cargo leakage and high nuclease resistance. Force-induced release and uptake of DMC cargo is&nbsp;validated using&nbsp;flow cytometry. Finally, we demonstrate force-induced mRNA knockdown of HIF-1α in a manner that is dependent on the magnitude of cellular traction forces. These results show that DMCs can be effectively used to target biophysical phenotypes which may find useful applications in immunology and cancer biology.&nbsp;</p>